Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis.

Area of Science:

• Cell Biology
• Endocrinology
• Diabetes Research

Background:

• Type 2 diabetes involves beta-cell deficit, increased apoptosis, and islet amyloid formation.
• Human islet amyloid polypeptide (h-IAPP) oligomerization induces beta-cell apoptosis, unlike mouse IAPP.
• The failure of adaptive beta-cell mass increase in diabetes may stem from apoptosis during cell division.

Purpose of the Study:

• To investigate the hypothesis that beta-cells are preferentially vulnerable to h-IAPP-induced apoptosis.
• To determine if replicating beta-cells are more susceptible to apoptosis than non-dividing cells.
• To explore the potential for beta-cell mass recovery through apoptosis inhibition.

Main Methods:

• Utilized time-lapse video microscopy (TLVM) to study beta-cells (RIN) and HeLa cells undergoing replication and apoptosis.
• Quantified apoptosis rates and cell cycle vulnerability to freshly dissolved h-IAPP.
• Examined human pancreatic tissue and islets for postmitotic apoptosis using TUNEL staining.

Main Results:

• Freshly dissolved h-IAPP significantly increased apoptosis in both cell types in a dose-dependent manner.
• Cells undergoing mitosis, particularly beta-cells within 3 hours post-mitosis, showed heightened vulnerability to h-IAPP.
• Paired apoptotic cells, indicative of postmitotic apoptosis, were observed in human diabetic pancreatic tissue and h-IAPP-treated islets.

Conclusions:

• Replicating beta-cells exhibit preferential vulnerability to h-IAPP-induced apoptosis.
• Postmitotic apoptosis is a documented phenomenon in human type 2 diabetes and islet tissue.
• Beta-cell deficiency in type 2 diabetes may result from impaired adaptive mass increase due to replicating beta-cell apoptosis, suggesting apoptosis inhibition as a therapeutic strategy.